Wells Fargo & Company Iveric Bio, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$26.24 - $39.63 $398,900 - $602,455	15,202 Added 18.16%	98,896 $3.89 Million
Q1 2023 May 12, 2023	BUY	$18.67 - $24.56 $1.44 Million - $1.89 Million	77,154 Added 1179.72%	83,694 $2.04 Million
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $122,714 - $170,476	-7,118 Reduced 52.12%	6,540 $140,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $25,022 - $49,486	-2,662 Reduced 16.31%	13,658 $245,000
Q2 2022 Aug 12, 2022	SELL	$9.12 - $18.9 $469,771 - $973,538	-51,510 Reduced 75.94%	16,320 $156,000
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $473,084 - $655,309	-38,937 Reduced 36.47%	67,830 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $1.05 Million - $1.43 Million	76,030 Added 247.36%	106,767 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $79,113 - $195,825	11,190 Added 57.25%	30,737 $500,000
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $127,143 - $160,213	-22,345 Reduced 53.34%	19,547 $123,000
Q1 2021 May 13, 2021	SELL	$5.08 - $6.89 $672,200 - $911,705	-132,323 Reduced 75.95%	41,892 $259,000
Q4 2020 Feb 09, 2021	BUY	$5.65 - $7.66 $322,615 - $437,386	57,100 Added 48.76%	174,215 $1.2 Million
Q3 2020 Nov 05, 2020	BUY	$4.01 - $6.29 $373,824 - $586,372	93,223 Added 390.18%	117,115 $662,000
Q2 2020 Aug 13, 2020	BUY	$3.06 - $6.6 $71,154 - $153,469	23,253 Added 3638.97%	23,892 $123,000
Q1 2020 May 14, 2020	BUY	$2.83 - $8.44 $1,808 - $5,393	639 New	639 $2,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.